Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics After Oral Administration of DW1903, DW1903-R1 and DW1903-R2 in Healthy Adult Volunteers

A Randomized, Open-label, Oral in healthy male volunteers

Inclusion Criteria:

• Healthy Volunteers who are ≥19 years old
• BMI between 18 and 30 kg/m2
• Body weight ≥50kg

Exclusion Criteria:

•Clinically significant Medical History